InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: JTORENCE post# 229191

Thursday, 05/24/2018 3:42:45 PM

Thursday, May 24, 2018 3:42:45 PM

Post# of 402726
The only relevance here is its similarity to almost every single pre revenue biotech out there.
I have a pretty nice list too. These just about always get the crap beat out of them until a deal is made. The potential of that deal is the reason why this is still on the top 20 most read boards list. It's why you're here and so many others.
If everyone thought $IPIX would slide to oblivion through the night, no one would be here.

George may be pretty optimistic about value after approval and full market penetration but even if he's half right, this will make quite the mark.

Really no reason to mention prurisol and why it's taking so long. It is what it is. Once again reminded how CEO's shouldn't mention time lines they have no control over. We get the data when we get it. No hand holding required. Double blinded means just that. Go fish.

Brilacidin's pathway is being carved very nicely. If Leo did submit for breakthrough designation I hope he does keep it to himself till it's approved.

Here's what really counts...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140577387

So, it will be fun when cash flow from a partner hits pre market some morning.

Message in reply to:

Thank You, your just confirmed my post. Leo's rhetoric is not only tiresome , but a burden on investors as well as the SP.



Yes, I confirmed that many are just posting noise. $IPIX stands to have quite the future.

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News